Arcadia Biosciences, Inc. — Director's Dealing 2016

Mar 8, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-03-03

Reporting Person: Knauf Vic C. (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-03	Common Stock	M	300	$1.08	Acquired	47434	Direct
2016-03-03	Common Stock	S	300	$2.97	Disposed	47134	Direct
2016-03-04	Common Stock	M	2973	$1.08	Acquired	50107	Direct
2016-03-04	Common Stock	S	2973	$3.224	Disposed	47134	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-03	Employee Stock Option (right to buy)	$1.08	M	300	Disposed	2018-06-30	Common Stock (300)	Direct
2016-03-04	Employee Stock Option (right to buy)	$1.08	M	2973	Disposed	2018-06-30	Common Stock (2973)	Direct

Footnotes

F1: The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan adopted by the Reporting Person effective February 1, 2016.

F2: The option is fully exercisable as of the date hereof.